Trial Profile
A Drug Interaction Study to Assess the Pharmacokinetics of Narlaprevir and Antiretroviral Drugs
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Feb 2019
Price :
$35
*
At a glance
- Drugs Narlaprevir (Primary) ; Raltegravir; Ritonavir; Tenofovir disoproxil fumarate
- Indications Hepatitis C
- Focus Pharmacokinetics
- Sponsors R-Pharm
- 29 May 2018 New trial record